David M. Denton - 31 May 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role: Chief Financial Officer & EVP
Signature: Susan E. Grant, by power of atty., for David M. Denton
Issuer symbol: PFE
Transactions as of: 31 May 2022
Net transactions value: $0
Form type: 4
Filing time: 01 Jun 2022, 17:50:38 UTC
Previous filing: 09 May 2022
Next filing: 16 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Award	$0	+61,275	+6885%	$0.000000	62,165	31 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+80,703		$0.000000	80,703	31 May 2022	Common Stock	80,703	$53.04	Direct	F2
transaction	PFE	Stock Appreciation Rights	Award	$0	+70,313		$0.000000	70,313	31 May 2022	Common Stock	70,313	$53.04	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.